VeriMomoligopeptide-20 est-il sûr pendant la grossesse ?
No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
Pregnancy-safe products containing oligopeptide-20
Related ingredients
Frequently asked questions
- oligopeptide-20 est-il sûr pendant la grossesse ?
- No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
- oligopeptide-20 est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-related hazards in authoritative sources (no harmonised classification, no CIR/SCCS concerns, no peer‑reviewed data indicating transfer into milk). With negligible dermal absorption from topical cosmetic use, systemic exposure (and thus transfer into breastmilk) is expected to be negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed).
- oligopeptide-20 est-il sûr pour la peau de bébé ?
- No evidence of developmental/infant toxicity or mechanistic reproductive hazard. However, because infant skin has a less mature barrier and higher surface‑area‑to‑weight, a conservative increase in exposure rating is applied (+1) despite peptide’s generally poor dermal penetration; adult systemic exposure is expected negligible, but infant exposure potential is low but measurable for topical application (sources: general dermal absorption principles, CosIng, PubChem; no infant‑specific studies found in PubMed).
- Comment VeriMom évalue-t-il oligopeptide-20 ?
- VeriMom évalue oligopeptide-20 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-20 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-20 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.